Ultravist 370 Nueva Zelanda - inglés - Medsafe (Medicines Safety Authority)

ultravist 370

bayer new zealand limited - iopromide 769 mg/ml equivalent to iodine 370 mg/ml - solution for infusion - 370 mg/ml - active: iopromide 769 mg/ml equivalent to iodine 370 mg/ml excipient: hydrochloric acid sodium calcium edetate trometamol water for injection - for intravascular use and use in body cavities. contrast enhancement in computerised tomography (ct), arteriography and venography, intravenous/intra-arterial digital subtraction angiography (dsa), intravenous urography, use for ercp, arthrography and examination of other body cavities. ultravist 240: also for intrathecal use. ultravist 370: especially for angiocardiography. ultravist 300/370: not for intrathecal use.

Ultravist 300mg/ml Solution for Injection (50ml, 75ml, 100ml, 150ml, 200ml and 500ml) Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ultravist 300mg/ml solution for injection (50ml, 75ml, 100ml, 150ml, 200ml and 500ml)

bayer limited - iopromide - solution for injection - 300 milligram(s)/millilitre - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopromide

Ultravist 370mg/ml Solution for Injection (50 ml, 100ml, 150 ml, and 200 ml) Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ultravist 370mg/ml solution for injection (50 ml, 100ml, 150 ml, and 200 ml)

bayer limited - iopromide - solution for injection - 370 milligram(s)/millilitre - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopromide

Ultravist 240mg/ml Solution for Injection (50ml) Irlanda - inglés - HPRA (Health Products Regulatory Authority)

ultravist 240mg/ml solution for injection (50ml)

bayer limited - iopromide - solution for injection - 240 milligram(s)/millilitre - watersoluble, nephrotropic, low osmolar x-ray contrast media; iopromide

Ultravist 240 240 mg/ml inj./inf. sol. i.v. vial Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ultravist 240 240 mg/ml inj./inf. sol. i.v. vial

bayer sa-nv - iopromide 499 mg/ml - eq. iodine 240 mg/ml - solution for injection/infusion - 240 mg/ml - iopromide 499 mg/ml - iopromide

Ultravist 240 240 mg/ml inj./inf. sol. i.v. vial Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ultravist 240 240 mg/ml inj./inf. sol. i.v. vial

bayer sa-nv - iopromide 499 mg/ml - eq. iodine 240 mg/ml - solution for injection/infusion - 240 mg/ml - iopromide 499 mg/ml - iopromide

Ultravist 300 300 mg/ml inj./inf. sol. i.v. vial Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ultravist 300 300 mg/ml inj./inf. sol. i.v. vial

bayer sa-nv - iopromide 623 mg/ml - eq. iodine 300 mg/ml - solution for injection/infusion - 300 mg/ml - iopromide 623 mg/ml - iopromide

Ultravist 300 300 mg/ml inj./inf. sol. i.v. vial Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ultravist 300 300 mg/ml inj./inf. sol. i.v. vial

bayer sa-nv - iopromide 623 mg/ml - eq. iodine 300 mg/ml - solution for injection/infusion - 300 mg/ml - iopromide 623 mg/ml - iopromide

Ultravist 300 300 mg/ml inj./inf. sol. i.v. vial Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ultravist 300 300 mg/ml inj./inf. sol. i.v. vial

bayer sa-nv - iopromide 623 mg/ml - eq. iodine 300 mg/ml - solution for injection/infusion - 300 mg/ml - iopromide 623.4 mg/ml - iopromide

Ultravist 300 300 mg/ml inj./inf. sol. i.v. vial Bélgica - inglés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ultravist 300 300 mg/ml inj./inf. sol. i.v. vial

bayer sa-nv - iopromide 623 mg/ml - eq. iodine 300 mg/ml - solution for injection/infusion - 300 mg/ml - iopromide 623.4 mg/ml - iopromide